中国南方三座大城市男男性行为者肛门人乳头瘤病毒感染情况及HPV疫苗接种启示
2017年1月1日至8月31日在广州、深圳、无锡招募536名男男性行为者(MSM),检测肛门HPV DNA及HIV。HIV阳性MSM任何HPV基因型(79.5% vs 46.7%)、高危型(64.1% vs 36.6%)及九价疫苗可预防型(53.9% vs 31.6%)均显著高于HIV阴性者(P<0.01)。肛门HPV感染与HIV感染、娱乐性药物使用、性经验≥3年、终生男性伴侣≥6个及接受性肛交相关。
要点
- HIV阳性MSM肛门HPV感染率显著高于HIV阴性者(任何型79.5% vs 46.7%,P<0.01)。
- 肛门HPV感染随年龄增长而升高,<20岁为24.5%,≥40岁为55.8%。
- 作者认为可能有必要针对青少年MSM开展靶向HPV疫苗接种规划。
核心结论
- 中国南方MSM肛门HPV感染率较高,与HIV状态和性经验显著相关,且随年龄增长而升高。
- 作者认为可能有必要针对青少年MSM制定靶向HPV疫苗接种规划,研究结果将为中国MSM的靶向HPV模型提供信息。
研究设计与样本
- 于2017年1月1日至8月31日在广州、深圳和无锡三座城市招募MSM,共纳入536名MSM,其中HIV阳性39例、HIV阴性497例。
- 使用基于平板电脑的自填问卷收集社会人口学/性行为特征、性传播感染史及娱乐性药物使用信息,肛门拭子采集脱落细胞进行HPV DNA检测及基因分型,采血进行HIV检测,并由临床医生检查阴茎/肛门疣。
主要发现
- HIV阳性MSM任何HPV基因型患病率为79.5%,HIV阴性MSM为46.7%,差异显著(P<0.01)。
- HIV阳性MSM任何高危基因型患病率为64.1%,HIV阴性MSM为36.6%,差异显著(P<0.01)。
- HIV阳性MSM任何九价疫苗可预防基因型患病率为53.9%,HIV阴性MSM为31.6%,差异显著(P<0.01)。
- HIV感染(AOR 4.28,95%CI 1.87-9.80)、使用娱乐性药物(AOR 1.87,95%CI 1.22-2.87)、性经验≥3年(AOR 1.52,95%CI 1.01-2.28)、终生男性伴侣≥6个(AOR 1.92,95%CI 1.29-2.86)及接受性肛交(AOR 2.30,95%CI 1.48-3.57)与较高的肛门HPV患病率相关。
- 任何HPV患病率随年龄增长而升高,<20岁为24.5%,≥40岁为55.8%。
临床怎么用
- 作者认为可能有必要针对青少年MSM开展靶向HPV疫苗接种规划。
- 原文未据此给出其他临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Men who have sex with men (MSM), especially those infected with human immunodeficiency virus (HIV), are at disproportionate risk for human papillomavirus (HPV) infection. Data about anal HPV prevalence among MSM in southern China are limited. METHODS: MSM were recruited between January 1 and August 31, 2017 in three metropolitan cities: Guangzhou, Shenzhen and Wuxi. A self-completed tablet-based questionnaire was used to collect information about socio-demographic/sexual behavioral characteristics, history of sexually transmitted infections (STIs) and recreational drug use. An anal brush was used to collect exfoliated cells for HPV DNA testing and genotyping, and a blood sample was taken for HIV testing. Penile/anal warts were checked by a clinician. RESULTS: A total of 536 MSM were enrolled, including 39 HIV-positive and 497 HIV-negative individuals. Compared with HIV-negative MSM, prevalence of any HPV genotype (79.5% vs 46.7%), any high-risk genotype (64.1% vs 36.6%) and any nonavalent vaccine-preventable genotype (53.9% vs 31.6%) was significantly higher in HIV-positive MSM, with all P < 0.01. HIV infection (adjusted odds ratio [AOR], 4.28; 95% confidence interval [CI], 1.87-9.80), using recreational drugs (AOR, 1.87; 95% CI, 1.22-2.87), having ≥ 3 years of sexual experience (AOR, 1.52; 95% CI, 1.01-2.28), having ≥ 6 lifetime male partners (AOR, 1.92; 95% CI, 1.29-2.86), and engaging receptive anal intercourse (AOR, 2.30; 95% CI, 1.48-3.57) were associated with higher anal HPV prevalence. Any HPV prevalence increased with age, from 24.5% at < 20 years to 55.8% at ≥ 40 years. CONCLUSIONS: Anal HPV prevalence was high among MSM in southern China, significantly associated with HIV status and sexual experience. HPV prevalence increased with age among MSM. A targeted HPV vaccination program for teenage MSM might be necessary. Our findings will inform targeted HPV modelling among MSM in China.
引用
- Zhou Y, Lin YF, Meng X, et al. Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination. Vaccine. 2020. PMID: 32088017. doi:10.1016/j.vaccine.2020.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。